---
schema_version: "secwatch.filing_event.v1"
accession: "0001551306-26-000009"
form_type: "8-K"
ticker: "PGNY"
cik: "0001551306"
company_name: "Progyny, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:51:44.135400+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# Progyny expects Q4 2025 revenue, net income, Adj. EBITDA slightly above prior guidance

## Summary
- CEO cites favorable Q4 member engagement vs. November guidance.
- Expects Q4 revenue, net income and Adjusted EBITDA slightly above prior ranges.
- Update excludes non-cash impacts from departure of President Michael Sturmer.
- Presenting at 44th Annual JP Morgan Healthcare Conference on Jan 13, 2026.
- No specific revised figures provided; guidance remains qualitative.

## SEC filing metadata
- accession: 0001551306-26-000009
- form_type: 8-K
- ticker: PGNY
- cik: 0001551306
- company_name: Progyny, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551306/000155130626000009/0001551306-26-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551306/000155130626000009/pgny-20260112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001551306-26-000009
- JSON: https://secwatch.observer/filing/0001551306-26-000009.json
- Plain text: https://secwatch.observer/filing/0001551306-26-000009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.